These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 48105)

  • 1. Letter: Levamisole.
    Symoens J
    Lancet; 1975 Apr; 1(7911):867. PubMed ID: 48105
    [No Abstract]   [Full Text] [Related]  

  • 2. Levamisole: a synthetic immunopotentiator under evaluation.
    Hadden JW
    Clin Bull; 1975; 5(1):32-3. PubMed ID: 819182
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: diogenes syndrome.
    Flannery GR; Rolland JM; Nairn RC
    Lancet; 1975 Mar; 1(7909):750-1. PubMed ID: 47516
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Levamisole.
    Webster DJ; Hughes LE
    Lancet; 1975 Apr; 1(7912):917-8. PubMed ID: 47559
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Levamisole.
    Lancet; 1975 Mar; 1(7906):574-5. PubMed ID: 47045
    [No Abstract]   [Full Text] [Related]  

  • 6. Levamisole as an immunotherapeutic agent in the treatment of cancer.
    Amery WK
    World J Surg; 1977 Sep; 1(5):597-604. PubMed ID: 272084
    [No Abstract]   [Full Text] [Related]  

  • 7. Levamisole, the story and the lessons.
    Amery WK; Bruynseels JP
    Int J Immunopharmacol; 1992 Apr; 14(3):481-6. PubMed ID: 1618599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levamisole as an immunostimulant.
    Pár A
    Ther Hung; 1980; 28(4):163-7. PubMed ID: 6782693
    [No Abstract]   [Full Text] [Related]  

  • 9. [Levamisole as an immunoregulatory drug].
    Górska M
    Pol Tyg Lek; 1979 Apr; 34(14):553-5. PubMed ID: 377261
    [No Abstract]   [Full Text] [Related]  

  • 10. Levamisole and the new era of chemoimmunotherapy.
    Greenspan EM; Erlich R
    Cancer Invest; 1991; 9(1):111-24. PubMed ID: 2012993
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Levamisole in the treatment of cancer.
    Peters LJ; Withers HR
    Lancet; 1976 May; 1(7967):1020-1. PubMed ID: 57418
    [No Abstract]   [Full Text] [Related]  

  • 12. [Levamisole -- a drug modifying immunologic phenomena].
    Bogdanikowa B
    Postepy Hig Med Dosw; 1979; 33(2):125-46. PubMed ID: 384382
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Levamisole.
    Lancet; 1975 Feb; 1(7903):389. PubMed ID: 46527
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Levamisole.
    Lancet; 1975 Jan; 1(7899):151-2. PubMed ID: 46060
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Levamisole and bone-marrow restoration after chemotherapy.
    Lods JC; Dujardin P; Halpern GM
    Lancet; 1976 Mar; 1(7958):548. PubMed ID: 55833
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)].
    Sakharchuk II; Skakal'skaia LM
    Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Levamisole (NSC-177023) in clinical immunotherapy.
    Amery WK
    Cancer Treat Rep; 1976 Mar; 60(3):217. PubMed ID: 1260776
    [No Abstract]   [Full Text] [Related]  

  • 18. [Selected aspects of levamisole use in oncological clinical practice].
    Pawlicki M; Stryjewska B; Zarska M
    Nowotwory; 1979; 29(4):245-51. PubMed ID: 537926
    [No Abstract]   [Full Text] [Related]  

  • 19. Levamisole--a cautionary note.
    Lancet; 1979 Aug; 2(8137):291-2. PubMed ID: 88616
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angioimmunoblastic lymphadenopathy treated by levamisole].
    Youinou P; Andrieu JM; Herzog C
    Nouv Presse Med; 1979 Feb; 8(6):444. PubMed ID: 317971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.